Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Courses
  4. ESMO Preceptorship on Prostate Cancer 2024: Lugano

Session 5 - Non metastatic and metastatic castration-resistant disease

Participants clinical case discussion: A case of cardiac disfunction worsening with androgen deprivation therapy + androgen receptor pathway inhibitor in metastatic hormone-sensitive de novo prostate cancer

Date

19 Dec 2024

Session

Session 5 - Non metastatic and metastatic castration-resistant disease

Topics

Management of Systemic Therapy Toxicities;  Endocrine Therapy

Tumour Site

Prostate Cancer

Presenters

M. Rosellini, IT

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Metastatic CRPC: Current treatment

Presenter: S. Gillessen, CH

Session: Session 5 - Non metastatic and metastatic castration-resistant disease

Resources:

Slides

Webcast

PSMA-based therapies

Presenter: K. Herrmann, DE

Session: Session 5 - Non metastatic and metastatic castration-resistant disease

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.